FRA:3RB - Deutsche Boerse Ag - GB00B24CGK77 - Common Stock - Currency: EUR
FRA:3RB (3/7/2025, 7:00:00 PM)
63.9
+0.54 (+0.85%)
The current stock price of 3RB.DE is 63.9 EUR. In the past month the price increased by 1.01%. In the past year, price increased by 5.48%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRG.DE | PROCTER & GAMBLE CO/THE | 26.52 | 385.54B | ||
CPA.DE | COLGATE-PALMOLIVE CO | 27.28 | 73.29B | ||
KMY.DE | KIMBERLY-CLARK CORP | 19.99 | 44.54B | ||
HEN3.DE | HENKEL AG & CO KGAA VOR-PREF | 16.07 | 38.22B | ||
HEN.DE | HENKEL AG & CO KGAA | 14.33 | 34.07B | ||
MLSDN.PA | LA SAVONNERIE DE NYONS SACA | N/A | 0 |
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. The company is headquartered in Slough, Berkshire and currently employs 40,000 full-time employees. The company went IPO on 2007-10-23. The firm's operating segments comprise the Hygiene, Health, and Nutrition business. The Hygiene portfolio works to eliminate dirt, germs, pests, and odors with products such as Lysol, Finish, Air Wick, Harpic and Mortein. The Company’s Health portfolio offers various solutions that provide pain relief, protection, hygiene, and personal care to households across the world, through brands like Dettol, Durex, Gaviscon, Nurofen, Mucinex, Strepsils and Veet. The Nutrition business includes its infant and child nutrition, its adult nutrition and its range of vitamins, minerals, and supplements (VMS). Brands under Nutrition business include Enfa, Enfamil, Nutramigen, Airborne, Move Free and Neuriva. The Company’s brands also include Dettol, Lysol, Harpic, Finish, Durex, Mucinex, Enfamil and Move Free and more.
RECKITT BENCKISER GROUP PLC
103-105 Bath Road
SLOUGH BERKSHIRE GB
Employees: 40000
Company Website: https://www.reckitt.com/
Investor Relations: https://www.reckitt.com/investors/
Phone: 441753217800
The current stock price of 3RB.DE is 63.9 EUR. The price increased by 0.85% in the last trading session.
The exchange symbol of RECKITT BENCKISER GROUP PLC is 3RB and it is listed on the Deutsche Boerse Ag exchange.
3RB.DE stock is listed on the Deutsche Boerse Ag exchange.
28 analysts have analysed 3RB.DE and the average price target is 70.18 EUR. This implies a price increase of 9.83% is expected in the next year compared to the current price of 63.9. Check the RECKITT BENCKISER GROUP PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
RECKITT BENCKISER GROUP PLC (3RB.DE) has a market capitalization of 43.70B EUR. This makes 3RB.DE a Large Cap stock.
RECKITT BENCKISER GROUP PLC (3RB.DE) currently has 40000 employees.
RECKITT BENCKISER GROUP PLC (3RB.DE) has a support level at 61.62 and a resistance level at 63.9. Check the full technical report for a detailed analysis of 3RB.DE support and resistance levels.
The Revenue of RECKITT BENCKISER GROUP PLC (3RB.DE) is expected to decline by -3.76% in the next year. Check the estimates tab for more information on the 3RB.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RECKITT BENCKISER GROUP PLC (3RB.DE) has a dividend yield of 3.82%. The yearly dividend amount is currently 2.23. Check the full fundamental report for a detailed analysis of 3RB.DE dividend history, reliability and sustainability.
RECKITT BENCKISER GROUP PLC (3RB.DE) will report earnings on 2025-04-23.
The PE ratio for RECKITT BENCKISER GROUP PLC (3RB.DE) is 17.22. This is based on the reported non-GAAP earnings per share of 3.71 and the current share price of 63.9 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 3RB.DE.
ChartMill assigns a technical rating of 7 / 10 to 3RB.DE. When comparing the yearly performance of all stocks, 3RB.DE is one of the better performing stocks in the market, outperforming 74.39% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to 3RB.DE. 3RB.DE has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months 3RB.DE reported a non-GAAP Earnings per Share(EPS) of 3.71. The EPS decreased by -7.29% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.78% | ||
ROA | 5.85% | ||
ROE | 19.14% | ||
Debt/Equity | 1.09 |
ChartMill assigns a Buy % Consensus number of 76% to 3RB.DE. The Buy consensus is the average rating of analysts ratings from 28 analysts.
For the next year, analysts expect an EPS growth of 0.68% and a revenue growth -3.76% for 3RB.DE